Emmyon receives a new Australian patent for ursolic acid and a new European patent for tomatidine

January 11, 2019, Coralville, IA – Emmyon is pleased to announce that the Australian Patent Office has issued a new patent for the use of ursolic acid to increase muscle mass or reduce muscle atrophy, and the European Patent Office has issued a new patent for methods and compositions for treating muscle atrophy, increasing muscle mass and/or enhancing muscle formation using tomatidine.  These new patents, which are exclusively licensed to Emmyon from the University of Iowa Research Foundation, significantly expand Emmyon’s IP coverage around ursolic acid and tomatidine.  The patents’ lead inventor is Emmyon’s President, Chris Adams, MD, PhD.